In particular, agonists of peroxisome proliferator-activated receptor-α (PPAR-α), such as fenofibrate, have demonstrated anti-inflammatory, antioxidant, and neuroprotective effects in preclinical models of MS and related neuroinflammatory conditions. The gene discussed is PPARA; the disease is myeloid sarcoma.